Profound Medical Corp.
PROF
NASDAQ·Healthcare·Medical - Devices·Mkt cap $250.4M
$6.89
▲ +1.32%
P/E
98.43
Mkt Cap
$250.4M
52-Wk Range
$3.76–$8.95
52-Week Range
$3.76 - $8.95
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 67.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Profitability at risk
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
+3.5% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying PROF right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 6, 2026
Reported EPS of -$0.26 vs -$0.22 consensus (-18.2% surprise). Revenue of $2.5M vs $4.8M expected (-47.7%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-18.2%
Revenue trend · last 2Q
—
+12%
Q1 26
Q2 26
$5.3M
$2.5M
Margins · last 2Q
Gross
78.4%
Profit
382.0%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Raymond James · Jul 27, 2026
vs Industry
How PROF stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.